Re: Ca^y thuo^'c, patent, ethical issues

[Tuan V Nguyen <t.nguyen@garvan.unsw.edu.au>]

Cha`o ba'c DQ va` ca'c ba'c,

>***** Hi` hi`, ma^'y ba'c be^n U'c ca'nh ddo^`ng nhie^`u the^' ma` cow 
>boy U'c dda^'u su'ng cha^.m ho*n cow boy My~ a` ?(Joke) 

	Cowboy U'c kho^ng bie^'t du`ng su'ng nhua^`n nhuye^?n 
nhu+ cowboy My~, ne^n chu+a ru't su'ng la` dda~ bi. nga? 
ro^`i. Did have a chance!!! :-)

> Tuy nhie^n ba'c ma('ng co^ng ty My~ kho^ng bie^'t co' ddu'ng kho^ng ? 
>Ca'c co^ng ty du*o*.c o*? My~ ha^`u he^'t cu?a Suiseland, UK, Germany 
>... dda^'y ba'c o*i! Co^ng ty dda^`u na~o cu?a ho. o*? chi'nh quo^'c 
>co`n o*? My~ chi? la` nhu*~ng co^ng ty con(nhu*ng to ho*n cg^ ty me.) 
>ma` tho^i . Ba'c ma('ng Cow Boy My~ to^.i nghie^.p!!!!  

	Ba'c co' ve? be^nh vu+.c cho ma^'y anh cowboy, hay la` 
ba'c ddang la`m cho ma^'y anh na`y (j/k) :). Ba'c no'i ddu'ng 
la('m, pha^`n ddo^ng ca'c co^ng ty du+o+.c la` tu+` Thu.y 
Si?, Pha'p, DDu+'c va` A(ng Le^. Nhu+ng theo to^i bie^'t thi` 
Merck Sharp & Dhome (My~) va^~n la` number 1 tre^n the^' 
gio+'i, ro^`i anh Upjohn, Eli Lily, vv nu+~a. Co`n ma^'y anh 
Sandoz, Ciba Geigy (nghe no'i dda~ nha^.p nhau ro^`i) va` 
Roche hi`nh nhu+ chi? number 2 or 3 tho^i. Co`n Russell Uclaf 
(Pha'p) va` Wellcome, Glaxo (Anh) co' a(n nha^`m gi` vo+'i 
ma^'y anh kho^?ng lo^` My~. 

>>	Mi`nh la` nhu+~ng ngu+o+`i co' kinh nghie^.m chuye^.n 
>>na`y cho ne^n ca^`n pha?i ma'ch cho ca'c ba'c be^n VN. Va` 
>>to^i hoan nghe^nh chi. DQ trong vie^.c na`y.
>
> Nhu*ng co' ai nho*` mi`nh dda^u ha? ba'c ???? Ba('t dda^u` vo*'i ai va` 
>tu*` dda^u ? ???????? Co' ba'c na`o bie^'t ma'ch giu'p la`m phu*o*'c!

	To^i nghi~ co' nga`y ho. cu~ng se~ ca^`n ddo' tho^i. 
Ba'c cu+' ye^n ta^m. Cha(?ng bie^'t ba^y gio+` ho. ddang 
la`m gi` be^n a^'y? cha('c ddang busy thu+? nghie^.m tre^n 
be^.nh nha^n.


> Ba'c no'i nhu* the^' na`y la` ddo^`ng y' vo*'i ca^u cu?a to^i chu*' ?

	Absolutely!

>>	To^i co`n nho+' lu'c to^i co`n la`m cho trung ta^m 
>>Clinical Research o+? Basle, loa.i thuo^'c Cyclosporin 
>>(Sandimun) la` loa.i thuo^'c du`ng cho organ transplantation, 
>>pha?i ma^'t ngo't 20 na(m tu+` lu'c kha'm pha' cho to+'i 
>>marketing!
>>
>>	DDu+o+`ng co`n da`i dde^? ho^'t ba.c trie^.u!
>
>****** Va^ng, ta.i My~ cu~ng ma^'t khoa?ng 10 na(m (trung bi`nh) va` chi 
>phi' khoa?ng 100 trie^.u do^ la dde^? ddu*a mo^.t hoa' cha^'t mo*'i 
>tha`nh thuo^'c ba'n tre^n thi. tru*o*`ng .

	10 na(m la` so+'m dda^'y ba'c, chu+' tho^ng thu+o+`ng 
la` 20 na(m. Bo+?i va^.y ma^'y co^ng ty du+o+.c ho. 
jeaslously protect ca'i right cu?a ho. kinh la('m. Ho. la`m 
vie^.c ma` kho^ng publication nhie^`u dde^? ba?o ve^. ca'i 
go.i la` commercial secrecy!


> Ca'i quan tro.ng la` Contract ta ky' vo*'i ho. va` release ownership 
>cho ha~ng thuo^'c dde^? ho. develop tha`nh thuo^'c ba'n . Tuy` theo 
>ddie^`u kie^.n dda~ thoa? thua^.n va` ky'.

	Hi`nh nhu+ patent chi? co' hie^.u qua? trong vo`ng 5-10 
na(m, i.e. sau 5-10 na(m ai cu~ng co' the^? copy la`m thuo^'c 
ca?, pha?i kho^ng? 
 

> THeo to^i hie^?u khi ba'c nha^.n grant cu?a ho. ne^'u co' gi` pha'y 
>minh mo*'i thi` NIH (no*i cho grant) cu~ng co' ownership trong patent 
>nghie^n cu*'u ddo' va^.y . Ba'c nghi~ sao ?
> Regards

	DDu'ng va^.y. To^i tha^'y "la`m a(n" vo+'i NIH kho^? 
la('m. Ho. hoa.nh ho.e lia chia, la`m kho' la`m de^~ ddu? 
thu+' ca?. Tie^`n thi` kho^ng nhie^`u ma` ho. la`m nhu+ o^ng 
chu? mi`nh kho^ng ba(`ng.

	Cheers,


		Tua^'n